| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Abelson helper integration site 1 | 0.513 | 0.846 | 1.1E-25 |
|
disease | 0.340 | None | 1.000 | 0 | 0 | 2013 | 2019 | ||||||||
|
activin A receptor type 2B | 0.601 | 0.615 | 0.83 |
|
disease | 0.300 | limited | 0 | 0 | |||||||||||
|
adhesion G protein-coupled receptor V1 | 0.572 | 0.731 | 3.2E-39 |
|
disease | 0.300 | limited | 0 | 0 | |||||||||||
|
ADP ribosylation factor like GTPase 13B | 0.631 | 0.538 | 2.7E-09 |
|
disease | 0.340 | None | 1.000 | 0 | 0 | 2015 | 2019 | ||||||||
|
ADP ribosylation factor like GTPase 6 | 0.636 | 0.462 | 1.0E-02 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
aryl hydrocarbon receptor interacting protein like 1 | 0.644 | 0.346 | 1.2E-05 |
|
disease | 0.300 | limited | 0 | 0 | |||||||||||
|
ataxin 10 | 0.650 | 0.385 | 3.5E-04 |
|
disease | 0.300 | limited | 0 | 0 | |||||||||||
|
B9 domain containing 1 | 0.572 | 0.692 | 2.8E-03 |
|
disease | 0.310 | limited | 1.000 | 3 | 0 | 2011 | 2016 | ||||||||
|
B9 domain containing 2 | 0.606 | 0.577 | 5.3E-05 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2011 | 2015 | ||||||||
|
Bardet-Biedl syndrome 1 | 0.593 | 0.692 | 3.4E-12 |
|
disease | 0.310 | None | 1.000 | 0 | 0 | 2019 | 2019 | ||||||||
|
Bardet-Biedl syndrome 10 | 0.644 | 0.538 | 1.7E-12 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
Bardet-Biedl syndrome 12 | 0.674 | 0.462 | 2.3E-07 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
Bardet-Biedl syndrome 2 | 0.565 | 0.654 | 1.0E-17 |
|
disease | 0.360 | None | 1.000 | 0 | 0 | 2011 | 2019 | ||||||||
|
Bardet-Biedl syndrome 4 | 0.647 | 0.615 | 1.5E-16 |
|
disease | 0.310 | None | 1.000 | 0 | 0 | 2019 | 2019 | ||||||||
|
Bardet-Biedl syndrome 5 | 0.659 | 0.577 | 4.8E-06 |
|
disease | 0.310 | None | 1.000 | 0 | 0 | 2019 | 2019 | ||||||||
|
Bardet-Biedl syndrome 7 | 0.682 | 0.462 | 7.1E-09 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
Bardet-Biedl syndrome 9 | 0.615 | 0.577 | 4.2E-17 |
|
disease | 0.310 | None | 1.000 | 0 | 0 | 2012 | 2012 | ||||||||
|
cadherin related 23 | 0.539 | 0.769 | 3.2E-06 |
|
disease | 0.300 | limited | 0 | 0 | |||||||||||
|
centrosomal protein 164 | 0.711 | 0.462 | 4.8E-27 |
|
disease | 0.320 | strong | 1.000 | 0 | 0 | 2012 | 2014 | ||||||||
|
centrosomal protein 290 | 0.517 | 0.769 | 1.1E-60 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2006 | 2019 | ||||||||
|
centrosomal protein 41 | 0.636 | 0.500 | 3.6E-06 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
ciliogenesis and planar polarity effector 1 | 0.575 | 0.692 | 5.9E-36 |
|
disease | 0.340 | None | 1.000 | 0 | 0 | 2014 | 2019 | ||||||||
|
clarin 1 | 0.633 | 0.423 | 1.7E-08 |
|
disease | 0.300 | limited | 0 | 0 | |||||||||||
|
coiled-coil and C2 domain containing 2A | 0.532 | 0.692 | 1.7E-27 |
|
disease | 0.340 | None | 1.000 | 0 | 0 | 2008 | 2016 |